These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1725337)

  • 1. Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin.
    Filep JG; Hermán F; Battistini B; Chabrier PE; Braquet P; Sirois P
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S216-8. PubMed ID: 1725337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin mediates antiaggregatory and hypotensive actions of endothelin in anaesthetized beagle dogs.
    Hermán F; Magyar K; Chabrier PE; Braquet P; Filep J
    Br J Pharmacol; 1989 Sep; 98(1):38-40. PubMed ID: 2508983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin.
    Hermán F; Magyar K; Filep JG
    Thromb Haemost; 1991 Mar; 65(3):296-9. PubMed ID: 2048053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo antiaggregatory action of endothelin-1 is not mediated through the endothelin ETA receptor.
    Hermán F; Yano M; Filep JG
    Eur J Pharmacol; 1993 May; 236(1):143-6. PubMed ID: 8319738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
    Hermán F; Hadházy P; Magyar K
    Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.
    McMurdo L; Lidbury PS; Thiemermann C; Vane JR
    Br J Pharmacol; 1993 Jun; 109(2):530-4. PubMed ID: 8358553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1.
    D'Orléans-Juste P; Lidbury PS; Telemaque S; Warner TD; Vane JR
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S251-5. PubMed ID: 1725347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PGI2, CH-7284 and CH-7384 on spontaneous platelet aggregation and blood pressure of anaesthetized beagles.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S113-6. PubMed ID: 3073758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit.
    Thiemermann C; Lidbury PS; Thomas GR; Vane JR
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S138-41; discussion S142. PubMed ID: 2473289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins.
    Miura K; Yukimura T; Yamashita Y; Shimmen T; Okumura M; Yamanaka S; Imanishi M; Yamamoto K
    J Pharmacol Exp Ther; 1991 Jan; 256(1):11-7. PubMed ID: 1988651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium.
    Traverse JH; Judd D; Bache RJ
    Circulation; 1996 Feb; 93(3):558-66. PubMed ID: 8565176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous receptors mediate endothelin-1-induced changes in blood pressure, hematocrit, and platelet aggregation.
    McMurdo L; Lidbury PS; Corder R; Thiemermann C; Vane JR
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S185-8. PubMed ID: 7509940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelins release tissue plasminogen activator and prostanoids.
    Lidbury PS; Thiemermann C; Korbut R; Vane JR
    Eur J Pharmacol; 1990 Sep; 186(2-3):205-12. PubMed ID: 2127021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal actions of endothelin: interaction with prostacyclin.
    Chou SY; Dahhan A; Porush JG
    Am J Physiol; 1990 Oct; 259(4 Pt 2):F645-52. PubMed ID: 2221102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-B-receptors-dependent-inhibition of platelet aggregation in the CD-1 mouse.
    Labonté J; Bkaily G; d'Orléans-Juste P
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S184-6. PubMed ID: 11078372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.
    Thiemermann C; May GR; Page CP; Vane JR
    Br J Pharmacol; 1990 Feb; 99(2):303-8. PubMed ID: 2183912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 induces prostacyclin release from bovine aortic endothelial cells.
    Filep JG; Battistini B; Côté YP; Beaudoin AR; Sirois P
    Biochem Biophys Res Commun; 1991 May; 177(1):171-6. PubMed ID: 2043104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antiaggregatory effect of BM 13.177 on the spontaneous platelet aggregation in anaesthetized beagle dogs.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S90-3. PubMed ID: 3073773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.